ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.20
0.02%
US Tech 100
20,811.20
-1.10%
S&P 500
5,983.25
-0.50%
US Dollar vs CAD
1.42445
-0.23%
Bitcoin
91,905.50
0.51%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX

  6. Avecho Biotechnology Limited (AVE) Share Price

Avecho Biotechnology Limited

Avecho Biotechnology Limited (AVE)

AVE SA
0.0065
0.00
( 0.00% )
Updated: 20:42:32
Delayed by 20 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.0065
Bid
0.006
Ask
0.007
Volume
3,013,002
0.0065 Day's Range 0.007
0.001 52 Week Range 0.007
Market Cap
20.6M
Previous Close
0.0065
Open
0.007
Last Trade
12857
@
0.0065
Last Trade Time
21:29:16
Financial Volume
-
VWAP
-
Average Volume (3m)
4,772,870
Shares Outstanding
3,169,297,013
Dividend Yield
-
PE Ratio
-9.09
Earnings Per Share (EPS)
-0
Revenue
1.59M
Net Profit
-3.44M

About Avecho Biotechnology Limited

Sector
Pharmaceutical Preparations
Industry
Financial Services Div'd
Website
www.avecho.com.au
Headquarters
Melbourne, Victoria, Aus
Founded
1992
Avecho Biotechnology Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker AVE. The last closing price for Avecho Biotechnology was AUD0.01. Over the last year, Avecho Biotechnology shares have traded in a share price range of AUD 0.001 to AUD 0.007.

Avecho Biotechnology currently has 3,169,297,013 shares outstanding. The market capitalization of Avecho Biotechnology is AUD20.60 million. Avecho Biotechnology has a price to earnings ratio (PE ratio) of -9.09.

Ask ADVFN Intelligence (AI)

AVE Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0005-7.142857142860.0070.0070.005565183990.00611548DE
40.0035116.6666666670.0030.0070.003108007010.00545483DE
120.002562.50.0040.0070.00247728700.0047918DE
260.00452250.0020.0070.00145529940.00357861DE
520.0035116.6666666670.0030.0070.00140050490.00371312DE
156-0.0075-53.57142857140.0140.0230.00124863560.00537059DE
2600.0035116.6666666670.0030.0450.00131142330.01433997DE

AVE - Frequently Asked Questions (FAQ)

What is the current Avecho Biotechnology share price?
The current share price of Avecho Biotechnology is AUD 0.0065
How many Avecho Biotechnology shares are in issue?
Avecho Biotechnology has 3,169,297,013 shares in issue
What is the market cap of Avecho Biotechnology?
The market capitalisation of Avecho Biotechnology is AUD 20.6M
What is the 1 year trading range for Avecho Biotechnology share price?
Avecho Biotechnology has traded in the range of AUD 0.001 to AUD 0.007 during the past year
What is the PE ratio of Avecho Biotechnology?
The price to earnings ratio of Avecho Biotechnology is -9.09
What is the cash to sales ratio of Avecho Biotechnology?
The cash to sales ratio of Avecho Biotechnology is 20
What is the reporting currency for Avecho Biotechnology?
Avecho Biotechnology reports financial results in AUD
What is the latest annual turnover for Avecho Biotechnology?
The latest annual turnover of Avecho Biotechnology is AUD 1.59M
What is the latest annual profit for Avecho Biotechnology?
The latest annual profit of Avecho Biotechnology is AUD -3.44M
What is the registered address of Avecho Biotechnology?
The registered address for Avecho Biotechnology is UNIT A8, 2A WESTALL ROAD, CLAYTON, MELBOURNE, VICTORIA, 3168
What is the Avecho Biotechnology website address?
The website address for Avecho Biotechnology is www.avecho.com.au
Which industry sector does Avecho Biotechnology operate in?
Avecho Biotechnology operates in the FINANCIAL SERVICES DIV'D sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AVWAvira Resources Limited
AUD 0.01
(900.00%)
15k
WOAWide Open Agriculture Ltd
AUD 0.011
(120.00%)
108.75M
MOMMoab Minerals Ltd
AUD 0.002
(100.00%)
344
EXLOElixinol Wellness Limited
AUD 0.004
(100.00%)
250.28k
EVSEnviroSuite Limited
AUD 0.081
(88.37%)
8.03M
CVVOBCaravel Minerals Limited
AUD 0.005
(-54.55%)
108.53k
PFEOPantera Lithium Ltd
AUD 0.001
(-50.00%)
1.5M
AXLOAxel Ree Ltd
AUD 0.008
(-42.86%)
154.43k
JLGJohns Lyng Group Limited
AUD 2.525
(-33.90%)
22.35M
ACROAcrux Ltd
AUD 0.002
(-33.33%)
714.29k
WOAWide Open Agriculture Ltd
AUD 0.011
(120.00%)
108.75M
NMGNew Murchison Gold Ltd
AUD 0.011
(0.00%)
34.12M
ZIPZip Co Limited
AUD 2.79
(17.72%)
33.5M
AUHAustChina Holdings Limited
AUD 0.001
(0.00%)
31.71M
VEAViva Energy Group Limited
AUD 1.7925
(-25.31%)
29.99M

Discussion

View Full Feed
LongCA LongCA 1 minute ago
It was across the whole otc.  Curious swap ...

What that might foretell,  who knows..  but I hae not seem them since OTC was at least a bit liquid. 
TMMI
janice shell janice shell 2 minutes ago
That is truly heartwarming. Today he said, "Deals are all I know." I wouldn't dream of trying to argue that he knows anything else, but I would advance the notion that he knows nothing about cutting deals.
getmenews getmenews 4 minutes ago
Its amazing the concept of people comparing the value of bitcoin as its a limited supply, as compared to global GOLD mining, DOGE has an unlimited supply yet it failed to see a new high on the last penny stock run-up before a market crash this year, IE Coin exchanges, that, as it happens isn't suppo
XRPUSD
Lime Time Lime Time 4 minutes ago
Needs Verified Profile every 6 month and yeah, the Annual.
PAOG
janice shell janice shell 4 minutes ago
President Donald Trump celebrated on Sunday after German conservative opposition leader Friedrich Merz claimed victory in a national election, ousting Social Democrat incumbent Chancellor Olaf Scholz.

And what did Merz have to say about Trump and the US? Or did you miss that part of t
Adamph85 Adamph85 5 minutes ago
Yeah, it was VERY INTERESTING shift in L2 today. It makes you wonder...
TMMI
blackcat blackcat 6 minutes ago
This is an absolutely great idea!

https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:lhduvhsdlbp3vfv2afgkizrh/bafkreierpvtptwgfvtkpgefojmsdnhcwqw52bpzpktaebi3xtqghaakvaa@jpeg
axelvento axelvento 7 minutes ago
From Tumor Biology to Breakthrough Therapies: The Rise of Personalized Cancer Vaccines

Notably, in the KEYNOTE-942 trial (NCT03897881) led by Jeffrey S Weber, investigators observed improved relapse-free survival (RFS) with a combination of neoantigen vaccines and pembrolizumab (Keytr
MRNA
Tahoe2468 Tahoe2468 9 minutes ago

I wish everyone not in this stock could see this chart 
KRTL
XMaster2023 XMaster2023 9 minutes ago
Just Short Fuzzy Logic. It’s Ironic that they say LP is corrupt when LP is suing the 7 market makers for collusion.
NWBO
Tahoe2468 Tahoe2468 11 minutes ago

Going up tomorrow 👍 
KRTL
Lime Time Lime Time 11 minutes ago
Form 15 is a one page doc. Check box and scribble in integer of # of shareholders. It's very simple. CEO doesn't seem to want to save this for some reason.
MIKP
Whalatane Whalatane 11 minutes ago
Gr8. Feel free to shoot holes in my thesis / arguments. Most of these IHUB boards are largely exercises in cognitive bias ...looking for posters to reinforce your pt of view .
I'm the opposite . I welcome informed opposing opinions.
The 2 negatives / risks I've found currently wit
UNCY
LongCA LongCA 14 minutes ago
I thought I'd come here to see if anyone noticed the change on L2 today..
$TMMI 
TMMI
roadkilll roadkilll 14 minutes ago
Does DOGE work?
A new document undercuts Trump admin's denials about $400 million Tesla deal

FEBRUARY 24, 202512:22 PM ET

But NPR has obtained a State Department document detailing that Biden's State Department planned to spend just $483,000 in the 2025 fiscal ye
TSLA
dbing dbing 14 minutes ago
Be nice jerkoff. You’ll thank me next week.
NWBO
roadkilll roadkilll 15 minutes ago
Coal power plants charging the Tesal EVs'
How 'bout some real numbers on how many Teslas are expected to sell in India where they average disposable income is about $600 a year?
TSLA
955 955 15 minutes ago
French President Macron summoned to the WH over GB & France holding out over peace deal. Must see video. Trump greets Macron, gives him a bone crushing hand shake and won't let go, until he grimaces in pain. Absolutely hilarious!

Beginning @ 24 min mark
https://www.brighte
GlitteringCosmonaut90 GlitteringCosmonaut90 15 minutes ago
BNCM growth potential is looking strong. Anyone else feeling bullish?
BNCM
BDEZ BDEZ 16 minutes ago
Apple to invest more than $500 billion in the US over the next four years.
janice shell janice shell 17 minutes ago
Or the small dogs. He hates dogs.
BDEZ BDEZ 17 minutes ago
Berkshire Hathaway removes diversity and inclusion from annual report
KRISGO KRISGO 18 minutes ago
If Linda owes Linda $100 and the stock price is $0.25 and wants to pay it in shares, it takes 400 shares to square up Linda. If the stock price is $1, it only takes 100 shares.

So Linda, thinking the stock price is going to get to $10 anyway, would naturally rather the price be $0.25
NWBO
XMaster2023 XMaster2023 18 minutes ago
The market makers are much better at playing the shell game. Who sells shares they don’t have and who buys something and never pays for it? LP is lily white compared to your boss.
NWBO

Your Recent History

ASX
AVE
Avecho Biotechnology
ASX
A40
Alita Resources
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads